MARRONE BIO INNOVATIONS INC - COM (MBII) Institutional Ownership

CUSIP: 57165B106

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2022

Type / Class
Equity / COM
Symbol
MBII
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 57165B106?
CUSIP 57165B106 identifies MBII - MARRONE BIO INNOVATIONS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of MARRONE BIO INNOVATIONS INC - COM (MBII) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q3 0 $0 -$44,946,580 0
2022 Q2 38,768,174 $44,971,010 -$4,347,174 $1.16 55
2022 Q1 43,201,995 $46,669,948 -$2,158,878 $1.08 70
2021 Q4 45,317,755 $32,633,713 -$12,006,145 $0.72 71
2021 Q3 38,958,336 $35,094,043 -$2,980,749 $0.90 67
2021 Q2 58,480,854 $91,526,538 +$37,742,142 $1.66 67
2021 Q1 43,096,675 $90,063,975 +$4,363,160 $2.09 69
2020 Q4 57,035,489 $69,802,881 +$5,405,289 $1.25 60
2020 Q3 52,596,849 $62,351,281 +$912,719 $1.22 54
2020 Q2 51,807,774 $58,954,393 +$1,236,273 $1.17 52
2020 Q1 50,853,760 $40,450,746 +$726,309 $0.82 50
2019 Q4 49,866,393 $48,956,293 +$826,546 $1.01 46
2019 Q3 48,910,082 $67,084,250 +$2,414,602 $1.41 49
2019 Q2 47,028,242 $68,536,305 +$932,267 $1.50 47
2019 Q1 46,539,473 $69,135,498 -$39,539 $1.53 52
2018 Q4 46,554,847 $66,474,152 +$217,194 $1.47 43
2018 Q3 46,375,086 $82,398,180 +$48,467,170 $1.83 45
2018 Q2 19,022,417 $34,898,168 -$24,268,048 $1.84 43
2018 Q1 32,436,773 $62,801,000 +$39,670,449 $2.00 23
2017 Q4 11,752,354 $12,927,550 -$55,723 $1.10 16
2017 Q3 11,799,722 $13,567,575 -$135,443 $1.15 20
2017 Q2 11,899,287 $15,127,645 +$3,553,751 $1.29 20
2017 Q1 8,997,620 $17,546,000 -$247,742 $1.95 22
2016 Q4 9,130,348 $19,536,000 -$415,100 $2.14 21
2016 Q3 9,343,401 $16,061,000 -$1,021,848 $1.72 20
2016 Q2 10,000,151 $8,200,000 +$17,533 $0.82 19
2016 Q1 9,980,016 $8,981,000 -$526,802 $0.90 18
2015 Q4 10,528,188 $11,582,000 -$597,402 $1.10 22
2015 Q3 10,973,857 $23,154,600 -$847,577 $2.11 30
2015 Q2 11,394,875 $22,559,087 -$8,530,883 $1.98 34
2015 Q1 13,346,590 $51,656,852 -$368,478 $3.87 40
2014 Q4 13,462,927 $48,599,879 +$1,656,107 $3.61 36
2014 Q3 13,466,047 $35,818,538 -$29,718,968 $2.66 45
2014 Q2 16,403,670 $190,611,000 +$69,004,243 $11.62 60
2014 Q1 10,460,956 $146,135,659 +$70,108,422 $13.97 48